Transcathether Cardiovascular Therapeutics Meeting In Brief
This article was originally published in The Gray Sheet
Executive Summary
Carotid stenting: MedNova EmboShield wire-filter distal protection system used with Xact self-expanding carotid stents is associated with a 7.2% 30-day major adverse event rate, according to preliminary results from the SECuRITY registry. Presented at the recent Transcatheter Cardiovascular Therapeutics meeting in Washington, D.C. by investigator Patrick Whitlow, MD, Cleveland Clinic, the data included evaluation of the devices in 305 patients with high surgical risks. The trial is being supported by Abbott Vascular, which has exclusive distribution rights (1"The Gray Sheet" Feb. 5, 2001, p. 23)...